Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT05050994
Eligibility Criteria:
Inclusion Criteria:
* Spleen length \> +2 standard deviations of normal limit
* Platelet count below 30-35 x 109 cells/L and a history of bleeding tendencies
* Symptoms of portal hypertension such as splenomegaly, thrombocytopenia, leucopenia, ascites, esophageal or gastric varices, hypertensive gastropathy, anal hemorrhoids and increased portal scintigraphy index, where alternative methods have not been enough or suitable
* A necessity for reduction of splenic volume due to splenic inhibition of motion and activity in the child
Exclusion Criteria:
* Age younger than 10 or older than 17 years of age
* Legal guardians or child do not give consent
* Ongoing infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
17 Years
Study:
NCT05050994
Study Brief:
Protocol Section:
NCT05050994